PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
April 5, 2026Cancer Research0 citations

Abstract 3286: The Warburg hijack of myeloid immunity via mitochondrial dysregulation in glioblastoma

View Full Paper
CKChun Wai Aeon KwokKKKarrie Mei Yee KiangGLGilberto Ka Kit Leung

Key Points

  • This investigation aims to understand how the Warburg effect alters myeloid cell functioning and contributes to glioblastoma development.
  • Re-analysis of RNA-sequencing data from GBM samples with lactate inhibition
  • Calculation of glycolytic activity and M2-like myeloid polarization scores
  • Comparison of pre-treated myeloid cell cultures with GBM proliferation and chemoresistance assessment
  • Live-cell imaging of myeloid cells with GBM tumor cells
  • Analysis of mitochondrial dynamics using Western blot and flow cytometry
  • High levels of M2-like immunosuppression and mitochondrial dysregulation observed
  • Reactive oxygen species mechanisms were identified under the Warburg environment
  • Correlation between Warburg signatures and mitochondrial dynamics was established
  • Poor survival rates linked to high LDHA levels were noted
  • Lactate-rich TME significantly impacts the effectiveness of pro-tumorigenic myeloid cells

Abstract

Abstract This study aims to illustrate how the Warburg effect drives glioblastoma (GBM) growth and development by dysregulating myeloid mitochondrial dynamics and evading myeloid immunity in the lactate-rich environment. The myeloid immunity is often reprogrammed and suppressed by GBM. A major driver is the lactate-rich, glycolysis-preferred metabolic tumor microenvironment (TME) established by the Warburg effect. Recent studies suggest that the Warburg metabolism shifts tumor-associated myeloid cells (macrophages and microglia) towards an anti-inflammatory, pro-tumorigenic phenotype and promotes glioblastoma growth by immunosuppressing local myeloid defence. Here, we investigate the interplay between the high-lactate acidic TME and myeloid evasion, with a specific focus on lactate-induced disruption of mitochondrial dynamics. We re-analyzed publicly available bulk RNA-sequencing data (GSE216070) from four GBM samples with and without pharmacological lactate inhibition. Glycolytic activity and M2-like myeloid polarization scores were calculated as the mean log2(CPM+1) expression of curated hallmark gene sets. The Warburg signatures were then correlated with gene sets reflecting reactive oxygen species regulation and inter- and intra-cellular mitochondrial dynamics. The analysis deciphers how lactate-driven metabolic rewiring of myeloid mitochondria contributes to GBM invasion and immune escape. To further understand how the Warburg effect orchestrates myeloid evasion in GBM, we propose to perform lactate pre-treated, vitamin C (lactate inhibitor) pre-treated and control myeloid cell cultures, then compare their pro-tumorigenic ability via conditioned medium in GBM proliferation and temozolomide chemoresistance assessment. In addition, the pre-treated myeloid cells will be seeded on the opposite side of μ-Dishes with GBM cells in between, to observe if there is any preferential growth or invasion towards either side under live-cell confocal imaging. The mitochondrial dynamics of the pre-treated cells will also be studied through Western blot and flow cytometry. Preliminary results showed high levels of M2-like immunosuppression, reactive oxygen species mechanism and mitochondrial dynamics and surveillance under the Warburg glycolysis environment. With the poor overall survival rate of high-LDHA patients from the Kaplan-Meier curve, the Warburg metabolism serves as a promising therapeutic target. Our study elucidates how Warburg metabolism promotes GBM immune evasion and invasion by inducing mitochondrial dysregulation in brain myeloid cells via the lactate-rich tumor microenvironment. Citation Format: Chun Wai Aeon Kwok, Karrie Mei Yee Kiang, Gilberto Ka Kit Leung, . The Warburg hijack of myeloid immunity via mitochondrial dysregulation in glioblastoma abstract. In: Proceedings of the American Association for Cancer Research Annual Meeting 2026; Part 1 (Regular Abstracts); 2026 Apr 17-22; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2026;86(7 Suppl):Abstract nr 3286.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Kwok et al. (2026) studied this question.

synapsesocial.com/papers/69d1fc8ea79560c99a0a2352https://doi.org/10.1158/1538-7445.am2026-3286
Ask AI
Helpful
Bookmark
Share
View Full Paper